[1]李珺,张玮,王高强,等.实脾固肾化瘀方对慢性心肾综合征患者AMPK/SIRT1/NF-κB信号通路的影响[J].西部中医药,2021,34(10):107-110.[doi:10.12174/j.issn.2096-9600.2021.10.26]
 LI Jun,ZHANG Wei,WANG Gaoqiang,et al.Impacts of Spleen-kidney-strengthening Stasis-removing Prescription on AMPK/SIRT1/NF-κB Signaling Pathway in Patients with Chronic Cardiorenal Syndrome[J].Western Journal of Traditional Chinese Medicine,2021,34(10):107-110.[doi:10.12174/j.issn.2096-9600.2021.10.26]
点击复制

实脾固肾化瘀方对慢性心肾综合征患者AMPK/SIRT1/NF-κB信号通路的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年10期
页码:
107-110
栏目:
临证经验
出版日期:
2021-10-15

文章信息/Info

Title:
Impacts of Spleen-kidney-strengthening Stasis-removing Prescription on AMPK/SIRT1/NF-κB Signaling Pathway in Patients with Chronic Cardiorenal Syndrome
作者:
李珺 张玮 王高强 岳艳利 杨盼 刘涵荫 沈丽萍
上海市杨浦区中医医院,上海 200090
Author(s):
LI Jun ZHANG Wei WANG Gaoqiang YUE Yanli YANG Pan LIU Hanyin SHEN Liping
Shanghai City Yangpu District Hospital of TCM, Shanghai 200090, China
关键词:
心肾综合征慢性实脾固肾化瘀方核因子B信号通路炎症
Keywords:
cardiorenal syndrome chronicspleen-kidney-strengthening stasis-removing prescriptionNF-Bsignaling pathwayinflammation
分类号:
R714.14+4
DOI:
10.12174/j.issn.2096-9600.2021.10.26
摘要:
目的探讨实脾固肾化瘀方治疗慢性心肾综合征的疗效及其对AMP活化蛋白激酶(AMP-activated protein kinase,AMPK)/沉默调节蛋白1(silencing regulator 1,SIRT1)/核因子κB(nuclear factor κB,NF-κB)信号通路的影响。 方法选择慢性心肾综合征患者96例,根据随机数字法分为观察组和对照组,每组48例。对照组予以常规治疗,观察组在对照组的基础上予以实脾固肾化瘀方治疗。观察两组治疗后的疗效,治疗前后内生肌酐清除率(creatinine clearance,Ccr)、24 h尿蛋白、尿白蛋白排泄率(urinary albumin excretion rate,UAER)、胱抑素C(cystatin C,CysC)、NT-proBNP、左室射血分数(left ventricular ejection fraction,LVEF)、左室收缩末期内径(left ventricular end-systolic diameter,LVESD)、左室舒张末期内径(left ventricular end-diastolic diameter,LVEDD)、肾脏动脉内径(renal artery diameter,D)、肾血流量(renal blood flow volume,V)、阻力指数(resistance index,RI),AMPK,SIRT1和NF-κB水平的变化。 结果治疗后观察组总有效率[85.42%(41/48)]明显高于对照组[64.58%(31/48)](P<0.05);治疗后两组Ccr、D、V、AMPK及SIRT1较治疗前明显升高(P<0.01),而24 h尿蛋白、UAER、CysC、RI及NF-κB水平较治疗前明显降低(P<0.01),观察组改善水平较对照组更明显(P<0.01)。 结论实脾固肾化瘀方治疗慢性心肾综合征疗效显著,能够改善心肾功能,增加肾脏血流量,抑制机体的炎症,其机制与抑制AMPK/SIRT1/NF-κB信号通路有关。
Abstract:
ObjectiveTo discuss clinical effects of spleen-kidney-strengthening stasis-removing prescription in treating chronic cardiorenal syndrome and its influence on AMPK/SIRT1/NF-κB signaling pathway. MethodsAll 96 patients were chosen, divided into the observation group and the control group according to random number table method, 48 cases in each group. The control group accepted conventional therapy, the observation group took spleen-kidney-strengthening stasis-removing prescription orally on the foundation of conventional therapy. To observe clinical effects after treating of the two groups, Ccr, 24 h urinary protein, UAER, CysC, NT-proBNP, LVEF, LVESD, LVEDD, D, V, RI, the levels of AMPK, SIRT1 and NF-κB before and after treating. ResultsAfter treating, total effective rate of the observation group was [85.42%(41/48)], notably higher than [64.58%(31/48)] (P<0.05); after treating, Ccr, D, V, AMPK and SIRT1 of both groups increased notably than these before treating (P<0.01), while the levels of 24 h urinary protein, UAER, CysC, RI and NF-κB lowered notably than these before treating (P<0.01), the improvements of the observation group were more notable than these of the control group (P<0.01). ConclusionSpleen-kidney-strengthening stasis-removing prescription is effective in treating chronic cardiorenal syndrome, it could improve cardiorenal function, increase renal blood flow, inhibit the inflammation of human body, and its mechanim might be related to inhibiting AMPK/SIRT1/NF-κB signaling pathway.

相似文献/References:

[1]周胜元,刘玥,陆小左.从中西医结合角度探讨心肾综合征的发病机制与治疗[J].西部中医药,2013,26(01):121.
 ZHOU Shengyuan,LIU Yue,LU Xiaozuo.Discussion on Pathogenesis and Therapy of Cardiorenal Syndrome in the View of Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(10):121.
[2]崔毅.益气活血汤治疗慢性盆腔炎64例临床观察[J].西部中医药,2012,25(12):75.
 CUI Yi.Clinical Observation on YiQi HuoXueTang and Activating Blood Decoction in Treating 64 Cases of Chronic Pelvic Inflammatory Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(10):75.
[3]樊斗霜.枳实消痞丸(汤)合丹参饮加减治疗慢性萎缩性胃炎32例[J].西部中医药,2013,26(02):72.
 FAN Doushuang.Modified ZhiShi XiaoPiWan(Prescription) and DanShenYin in Treating 32 Cases of Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(10):72.
[4]尤海鹰.制萎煎治疗脾胃虚弱型慢性萎缩性胃炎40例[J].西部中医药,2013,26(03):84.
 YOU Haiying.ZhiWeiJian in Treating 40 Cases of Chronic Atrophic Gastritis of Spleen-stomach Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(10):84.
[5]张建平,刘洁,赵志亮.针灸治疗慢性前列腺炎25例疗效观察[J].西部中医药,2013,26(03):111.
 ZHANG Jianping,LIU Jie,ZHAO Zhiliang.Observation on Acupuncture in Treating 25 Cases of Chronic Prostatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(10):111.
[6]魏国俊,郑恒恒,指导:燕中.损伤胶囊与正骨水治疗慢性软组织损伤疗效比较[J].西部中医药,2013,26(11):8.
 WEI Guojun,ZHENG Hengheng,Director: YAN Zhong.The Difference in Clinical Effects between SunShang Capsule and Bonesetting Liquid in Treating Chronic Soft Tissue Injury[J].Western Journal of Traditional Chinese Medicine,2013,26(10):8.
[7]朱建坤,温晓辉,梁玉杰△.敦煌葆元膏对下丘脑-垂体-肾上腺轴作用的实验研究*[J].西部中医药,2013,26(11):13.
 ZHU Jiankun,WEN Xiaohui,LIANG Yujie.Experimental Study on the Effects of DunHuang BaoYuan Ointment on Hypothalamic-pituitary-adrenal Axis[J].Western Journal of Traditional Chinese Medicine,2013,26(10):13.
[8]孙国荣,景克荣,权亚喜.生脉注射液对慢性心衰患者心功能及其心率变异性的影响[J].西部中医药,2013,26(04):68.
 SUN Guorong,JING Kerong,QUAN Yaxi.The Influence of ShengMai Injection on Heart Function and Heart Rate Variability of Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(10):68.
[9]俄静,夏小军,杨楠.益气温阳法治疗慢性血小板减少性紫癜经验举隅[J].西部中医药,2013,26(06):58.
 E Jing,XIA Xiaojun,YANG Nan.Invigorating Qi and Yang Method in Treating Chronic Thrombocytopenic Purpura[J].Western Journal of Traditional Chinese Medicine,2013,26(10):58.
[10]马继利.中西药物联用治疗慢性萎缩性胃炎58例[J].西部中医药,2013,26(06):91.
 MA Jili.Treatment for 58 Cases of Chronic Atrophic Gastritis with Integrative Medicines[J].Western Journal of Traditional Chinese Medicine,2013,26(10):91.

备注/Memo

备注/Memo:
李珺(1983—),女,硕士学位,主治医师。研究方向:糖尿病肾病、慢性肾脏病的诊治。上海市杨浦区卫生计生系统“好医师”建设工程项目[ZY(2018-2020)-FWTX-6018]。
更新日期/Last Update: 2021-10-15